Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Harvard Business School
Argus Health
Baxter
UBS
Cipla
Boehringer Ingelheim
Mallinckrodt

Generated: February 17, 2019

DrugPatentWatch Database Preview

Litigation Details for ORION CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES INC. (D.N.J. 2007)

« Back to Dashboard

ORION CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES INC. (D.N.J. 2007)

Docket ➤ Sign Up Date Filed 2007-11-13
Court District Court, D. New Jersey Date Terminated 2010-07-26
Cause 35:145 Patent Infringement Assigned To Mary Little Cooper
Jury Demand None Referred To Magistrate Judge Douglas E. Ar
Parties GWENDOLYN ZENO; NOVARTIS PHARMACEUTICAL CORPORATION; ORION CORPORATION; SUN PHARMA GLOBAL, INC.; SUN PHARMACEUTICAL INDUSTRIES INC.; SUN PHARMACEUTICAL INDUSTRIES LIMITED
Patents 4,963,590; 5,112,861; 5,135,950; 5,446,194; 6,500,867; 6,599,530; 6,797,732
Attorneys GREGORY S. THOMAS; JOSEPH F. LAGROTTERIA; KEVIN M. HART; MARTIN P. SCHRAMA; MICHAEL JAY PLATA
Firms Stark & Stark, PC
Link to Docket External link to docket
Small Molecule Drugs cited in ORION CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES INC.
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up and ➤ Sign Up .

Details for ORION CORPORATION v. SUN PHARMACEUTICAL INDUSTRIES INC. (D.N.J. 2007)

Date Filed Document No. Description Snippet Link To Document
2010-02-22 220 infringed its U.S. Patent Nos. 6,500,867 (the “‘867 patent”) and 5,446,194 (the “‘ 194 patent”) by submitting…Ltd., including patent-related information that Ms. Zeno obtained from Novartis patent counsel.” Id. at…exclusive licensee of the ‘867 and ‘ 194 patents, which arc the patents-in-suit in this litigation The allegedly… exclusive licensee for both the ‘194 and ‘867 patents, and holds an exclusive distributorship, supply…marketing materials that removed any reference to patent expiry or generic threats as well as a second privilege External link to document
2010-07-26 231 that claim 3 of U.S. Patent No. 5,446,194 (the “Asserted Claim of the ‘ 194 Patent”) would be infringed…Agreernent), that the Asserted Claim of the '194 Patent is valid and enforceable as to the Sun ANDA Products…defined in the Settlement Agreernent), that U.S. Patents 6,599,530 and 6,500,867 are valid and enforceable… 26 July 2010 3:07-cv-05436-MLC-DEA Patent None District Court, D. New Jersey External link to document
2009-01-27 48 Applicants’ employer, Orion, owns U.S. Patent No. 5,112,861 (“the ’861 patent”) (issued May 12, 1992), which …THE PATENT-IN-SUIT 3. The patent-in-suit is United States Patent No. 6,500,867 (“the ‘867 patent”), issued…the face of the patent shows that United States Patent No. 6,500,867 (“the ‘867 patent”) was issued on…ANDA listed the ‘867 patent and United States Patent No. 6,797,732 (“the ‘732 patent”), issued on September…purports to be an action for patent infringement arising under the patent laws of the United States. Sun External link to document
2009-02-09 51 10 of 25 Page|D: 597 14. U.S. Patent No. 4,963,590 (the ‘590 patent) issued on October 16, 1990 from…the ‘194 patent and the ‘530 patent, A copy of the ‘530 patent as obtained from the U.S. Patent and Trademark…the ‘ 194 patent or the ‘530 patent; 4. Declaring that that ‘ 194 patent and the ‘530 patents are invalid…the face of the patent shows that United States Patent No. 5,446,194 (“the ‘ 194 patent”) issued on August… Finland. II. THE PATENTS-IN-SUIT 3. The patents-in-suit are United States Patent No. 5 ,446,194 (“the External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Merck
Johnson and Johnson
UBS
McKinsey
Queensland Health
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.